Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

99
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
99
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

232
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
232
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

381
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
381
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

182
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
182
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

165
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
165
Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

149
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
149

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Current operative approaches for necrotizing enterocolitis.

World journal of pediatric surgery·2026
Same author

Rethinking probiotic delivery: new hope for preventing necrotizing enterocolitis.

Expert opinion on drug delivery·2026
Same author

Biofilm state Limosilactobacillus reuteri modulates aryl hydrocarbon receptor activity and suppresses experimental necrotizing enterocolitis.

Pediatric research·2025
Same author

Association of socioeconomic status with development and severity of necrotizing enterocolitis.

Journal of pediatric surgery·2025
Same author

Non-operative management of pediatric, uncomplicated acute appendicitis: A survey of pediatric surgeons' perceptions and practice.

Journal of pediatric surgery·2025
Same author

Reduction of prophylactic antibiotics for elective pediatric cholecystectomy: A QI initiative to promote antimicrobial stewardship.

Journal of pediatric surgery·2025

Related Experiment Video

Updated: Aug 6, 2025

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation
09:02

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation

Published on: February 15, 2018

19.5K

Current and future methods of probiotic therapy for necrotizing enterocolitis.

Nitin Sajankila1, Samantha Jane Wala1, Mecklin Victoria Ragan1

  • 1Department of Pediatric Surgery, Center for Perinatal Research, Nationwide Children's Hospital, Columbus, OH, United States.

Frontiers in Pediatrics
|March 20, 2023
PubMed
Summary

Necrotizing enterocolitis (NEC) prevention in premature infants remains a challenge. Probiotics show promise, but further research and product development are needed to establish clear guidelines for their safe and effective use in neonates.

Keywords:
NECdysbiosisgutintestinemicrobiomenecrotizing enterocolitisprobiotic

More Related Videos

Probiotic Studies in Neonatal Mice Using Gavage
10:36

Probiotic Studies in Neonatal Mice Using Gavage

Published on: January 27, 2019

19.6K
Author Spotlight: Enhancing Understanding and Treatment Strategies with the NEC-on-a-Chip Model
06:51

Author Spotlight: Enhancing Understanding and Treatment Strategies with the NEC-on-a-Chip Model

Published on: July 28, 2023

1.3K

Related Experiment Videos

Last Updated: Aug 6, 2025

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation
09:02

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation

Published on: February 15, 2018

19.5K
Probiotic Studies in Neonatal Mice Using Gavage
10:36

Probiotic Studies in Neonatal Mice Using Gavage

Published on: January 27, 2019

19.6K
Author Spotlight: Enhancing Understanding and Treatment Strategies with the NEC-on-a-Chip Model
06:51

Author Spotlight: Enhancing Understanding and Treatment Strategies with the NEC-on-a-Chip Model

Published on: July 28, 2023

1.3K

Area of Science:

  • Neonatal Medicine
  • Gastroenterology
  • Microbiology

Background:

  • Necrotizing enterocolitis (NEC) is a severe intestinal disease affecting premature infants, with high mortality and morbidity.
  • Current prophylactic measures are insufficient, creating a need for novel preventative strategies.
  • Probiotics are being investigated as a potential preventative therapy for NEC.

Purpose of the Study:

  • To review the current evidence on probiotics for NEC prevention in neonates.
  • To discuss the challenges and future directions for probiotic use in this population.
  • To explore next-generation probiotics and novel delivery strategies.

Main Methods:

  • Literature review of studies on probiotics and NEC.
  • Discussion of current probiotic products, safety, and efficacy concerns.
  • Exploration of emerging probiotic technologies and delivery methods.

Main Results:

  • There is significant interest in probiotics for NEC, but no clear guidelines or FDA-approved products exist.
  • Evidence regarding the benefits of probiotics in neonates is inconsistent, with safety and efficacy concerns.
  • Next-generation probiotics and novel delivery systems may offer improved risk-benefit profiles.

Conclusions:

  • Probiotics hold potential as an effective NEC prevention strategy.
  • Further research and product development are essential to optimize probiotic use in preterm infants.
  • Addressing safety and efficacy concerns is crucial for clinical implementation.